Related by context. Frequent words. (Click for all words.) 73 Chronic Lymphocytic Leukemia 72 Metastatic Melanoma 72 Metastatic Colorectal Cancer 72 Clinical Trial Results 71 Chronic Hepatitis C 70 Pivotal Phase 70 Carcinoma 70 Pivotal Phase III 70 Phase III Trial 70 Patients Treated 69 Glioma 69 Pivotal Trial 69 Phase III Clinical Trial 69 Elderly Patients 69 Epratuzumab 69 Acute Myeloid Leukemia 69 Monotherapy 68 Preclinical Data 68 Well Tolerated 68 Monoclonal Antibody 68 Drug Candidate 68 Autoimmune Diseases 68 Relapsed 67 Solid Tumors 67 Cell Lung Cancer 67 Metastatic 67 Completes Enrollment 67 Advanced Prostate Cancer 67 Overactive Bladder 67 Meta Analysis 66 Postmenopausal Women 66 Acute Myocardial Infarction 66 Pulmonary Arterial Hypertension 66 Tolerability 66 Benign Prostatic Hyperplasia 66 Heart Failure Patients 66 Prostate Cancer Patients 66 Ischemic 65 Chronic Heart Failure 65 Targeted Therapy 65 Patient Enrollment 65 Trastuzumab 65 Diabetic Patients 65 Bladder Cancer 65 Systemic Lupus Erythematosus 65 Breast Cancer Treatment 65 Presents Positive 64 Peripheral Artery Disease 64 Insulin Resistance 64 Thrombocytopenia 64 Alemtuzumab 64 Hepatitis C Virus 64 Breast Cancer Patients 64 Bevacizumab 64 Drug Resistant 64 Natalizumab 64 Epithelial 64 Ulcerative Colitis 64 Amrubicin 64 leukemia CLL 64 Lenalidomide 64 Monoclonal Antibodies 64 Bortezomib 64 Dasatinib 63 Immunogenicity 63 Asymptomatic 63 Inhibits 63 metastatic renal cell carcinoma 63 Irinotecan 63 relapsed refractory multiple myeloma 63 Glioblastoma 63 Initiates Phase 63 Vandetanib 63 Study Demonstrates 63 pheochromocytoma 63 Combination Therapy 63 myeloproliferative disorders 63 carcinoid 63 Multicenter 63 Acute Myeloid Leukemia AML 63 Cardiovascular Events 63 Induces 63 Liver Cancer 63 juvenile idiopathic arthritis 63 tumor lysis syndrome 62 Atopic Dermatitis 62 Traficet EN 62 myelodysplastic syndrome MDS 62 lupus nephritis 62 Esophageal Cancer 62 Cancer Cells 62 Voreloxin 62 castration resistant prostate cancer 62 PsA 62 Lymphomas 62 Rheumatoid Arthritis 62 RNAi Therapeutics 62 acute myelogenous leukemia AML 62 Rheumatoid Arthritis RA 62 CA4P 62 Shows Promise